COURT WILL NOT ISSUE SUMMARY JUDGMENT ON CONSISTENT TREATMENT ISSUE.
GlaxoSmithKline Holdings (Americas) Inc. et al. v. Comm.
- Case NameGLAXOSMITHKLINE HOLDINGS (AMERICAS) INC. & SUBSIDIARIES, Petitioner v. COMMISSIONER OF INTERNAL REVENUE, Respondent
- CourtUnited States Tax Court
- DocketNo. 5750-04
- JudgeCohen, Mary Ann
- Cross-ReferenceFor the GlaxoSmithKline memorandum in opposition to summary judgment
- Code Sections
- Subject Area/Tax Topics
- Jurisdictions
- LanguageEnglish
- Tax Analysts Document NumberDoc 2005-6933
- Tax Analysts Electronic Citation2005 TNT 64-14
GlaxoSmithKline Holdings (Americas) Inc. et al. v. Comm.
UNITED STATES TAX COURT
ORDER
On December 23, 2004, respondent filed with the Court in the above case (1) a Motion for Partial Summary Judgment, (2) Respondent's Memorandum of Law in Support of Respondent's Motion for Partial Summary Judgment, and (3) Affidavit of Theodore J. Kletnich. On February 22, 2005, Petitioner's Memorandum in Opposition to Respondent's Motion for Partial Summary Judgment was filed. On March 30, 2005, Respondent's Reply Memorandum of Law in Response to Petitioner's Memorandum in Opposition to Respondent's Motion for Partial Summary Judgment was filed.
The legal issue on which respondent seeks partial summary judgment, generally involving the right of a taxpayer to consistent treatment with other taxpayers, is not fully developed and is not resolved by any existing precedent. Respondent's contention that, in any event, petitioner is not "similarly situated" to another taxpayer requires evidentiary development as well as legal argument. Facts material to the issue that respondent seeks to foreclose are also material to the balance of transfer pricing issues in this case. An order granting respondent's motion would not satisfy the requirements for an interlocutory appeal under I.R.C. section 7482(a)(2)(A), because an immediate appeal from such an order would not materially advance the ultimate termination of the litigation. Thus, resolution of this important issue made in summary fashion would create a risk of mutiplicity of proceedings and delay in ultimate resolution of this case, and granting respondent's motion would undermine the purpose of summary judgment, which is to expedite litigation.
No views on the ultimate merits of the respective positions of the parties are implied by this Order, which is based on the conclusion that summary disposition at this time is neither appropriate nor practicable. Upon due consideration and for cause, it is hereby
ORDERED: That respondent's Motion for Partial Summary Judgment, filed December 23, 2004, is denied.
Judge
March 31, 2005
- Case NameGLAXOSMITHKLINE HOLDINGS (AMERICAS) INC. & SUBSIDIARIES, Petitioner v. COMMISSIONER OF INTERNAL REVENUE, Respondent
- CourtUnited States Tax Court
- DocketNo. 5750-04
- JudgeCohen, Mary Ann
- Cross-ReferenceFor the GlaxoSmithKline memorandum in opposition to summary judgment
- Code Sections
- Subject Area/Tax Topics
- Jurisdictions
- LanguageEnglish
- Tax Analysts Document NumberDoc 2005-6933
- Tax Analysts Electronic Citation2005 TNT 64-14